Red Violet, Inc.

RDVT

CIK 0001720116 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$23M
↑+19.6% +$4Mvs FY2024 (Q4)
Operating Income
$2M
↑+331.3% +$1Mvs FY2024 (Q4)
Net Income
$1M
↑+40333.3% +$1Mvs FY2024 (Q4)
Gross Profit
$20M
↑+21.2% +$3Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
79/100
  • Profitability
    38ROIC 12.7% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 7.18 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    51Asset Turnover 0.86x (1.0+ = capital-efficient)
  • Growth
    82Revenue YoY +19.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 6.8% · trend +4.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project RDVT's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 33.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$66.69
Total enterprise IV
$960M
Diluted shares
0.01B
Terminal PV
$745M (78% of total)
Year-5 FCF
$88M
YearProjected FCFDiscounted PV
+1$36M$33M
+2$45M$37M
+3$56M$42M
+4$70M$48M
+5$88M$55M
Terminal$1.20B$745M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$563K
investment in PP&E
Stock buybacks (TTM)
$915K
share count reduction
Stock-based comp (TTM)
$7M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$112M
everything owned
Total liabilities
$11M
everything owed
Stockholders' equity
$101M
shareholder claim
Net debt
$-44M
Net cash position ($44M)

Recent performance · 36 quarters

Revenue↑+19.6% +$4M
$23M
Net Income↑+226.2% +$2M
$3M
Free Cash Flow↓-1.6% -$109K
$7M
Operating Margin↑+4.9pts
6.8%

Drill down